Tekturna HCT and Breastfeeding: An Overview
) passes through breast milk. The manufacturer recommends that women avoid this drug while breastfeeding. If you are breastfeeding or are thinking about breastfeeding, talk with your healthcare provider before taking Tekturna
Tekturna HCT and Breastfeeding: What Does the Research Say?
Tekturna HCT contains two different medications: aliskiren
) and hydrochlorothiazide
(also known as HCTZ
No studies have been done to see if aliskiren passes through breast milk in women. However, it has been shown to pass through breast milk in rats, which is a good indication that it does so in humans as well. Hydrochlorothiazide does pass through breast milk in low amounts (probably too low to affect a breastfed infant). However, there is some concern that hydrochlorothiazide could decrease a woman's milk supply.
Talking With Your Healthcare Provider About Tekturna HCT and Breastfeeding
You should talk with your healthcare provider about Tekturna HCT and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Tekturna HCT and breastfeeding that is right for you.